Deborah Kuk

8.1k total citations · 1 hit paper
78 papers, 4.6k citations indexed

About

Deborah Kuk is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Deborah Kuk has authored 78 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 33 papers in Pulmonary and Respiratory Medicine and 13 papers in Immunology. Recurrent topics in Deborah Kuk's work include Sarcoma Diagnosis and Treatment (18 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Cardiac tumors and thrombi (7 papers). Deborah Kuk is often cited by papers focused on Sarcoma Diagnosis and Treatment (18 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Cardiac tumors and thrombi (7 papers). Deborah Kuk collaborates with scholars based in United States, Brazil and Israel. Deborah Kuk's co-authors include Mithat Gönen, Murray F. Brennan, Samuel Singer, Li‐Xuan Qin, Jedd D. Wolchok, Peter J. Allen, Narasimhan P. Agaram, Aimeé M. Crago, Ravi Varadhan and Katherine S. Panageas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Deborah Kuk

77 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Integrated NY-ESO-1 antibody and CD8⁺T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

2011 254 citations Jianda Yuan, Matthew Adamow et al. profile →

Peers

Countries citing papers authored by Deborah Kuk

Since Specialization

Citations

This map shows the geographic impact of Deborah Kuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Kuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Kuk more than expected).

Fields of papers citing papers by Deborah Kuk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Kuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Kuk. The network helps show where Deborah Kuk may publish in the future.

Co-authorship network of co-authors of Deborah Kuk

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Kuk. A scholar is included among the top collaborators of Deborah Kuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Kuk. Deborah Kuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Glucosamine and Chondroitin Use and Mortality Among Adults in the United States from 1999 to 2014 2023 ·Journal of Integrative and Complementary Medicine ·(unknown), Kelli O’Connell, Deborah Kuk, Mengmeng Du, Sandi L. Navarro, Elizabeth D. Kantor	2
2	Validation of diagnosis codes to identify side of colon in an electronic health record registry 2019 ·BMC Medical Research Methodology ·Patricia Luhn, Deborah Kuk, Gillis Carrigan, Nathan C. Nussbaum, Rachael Sorg, (unknown), Melisa Tucker, Brandon Arnieri, Michael D. Taylor, Neal J. Meropol	21
3	Adenoma Prevalence in Blacks and Whites Having Equal Adherence To Screening Colonoscopy: The National Colonoscopy Study 2017 ·Clinical Gastroenterology and Hepatology ·Robin B. Mendelsohn, Sidney J. Winawer, (unknown), Glenn Mills, Paul Jordan, Michael J. O’Brien, (unknown), (unknown), Timothy R. Church, Margaret T. Mandelson, John I. Allen, Andrew Feld, Noah D. Kauff, (unknown), (unknown), (unknown), (unknown), Sara Fischer, Deborah Kuk, Ann G. Zauber	4
4	Size and Location are the Most Important Risk Factors for Malignant Behavior in Resected Solitary Fibrous Tumors 2017 ·Annals of Surgical Oncology ·Sepideh Gholami, Michael R. Cassidy, Amanda Kirane, Deborah Kuk, (unknown), (unknown), Samuel Singer, Murray F. Brennan	63
5	Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma 2016 ·Sarcoma ·Alexander N. Shoushtari, Jonathan Landa, Deborah Kuk, Alejandro Sánchez, (unknown), (unknown), Chizimuzo T.C. Okoli, Ping Chi, Mark A. Dickson, Mrinal M. Gounder, Mary Louise Keohan, Aimeé M. Crago, William D. Tap, Sandra P. D’Angelo	11
6	Morphological characterization of colorectal cancers in The Cancer Genome Atlas reveals distinct morphology–molecular associations: clinical and biological implications 2016 ·Modern Pathology ·Jinru Shia, Nikolaus Schultz, Deborah Kuk, Efsevia Vakiani, Sumit Middha, Neil H. Segal, Jaclyn F. Hechtman, Michael F. Berger, Zsofia K. Stadler, Martin R. Weiser, Jedd D. Wolchok, C. Richard Boland, Mithat Gönen, David S. Klimstra	69
7	Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma 2015 ·British Journal of Cancer ·Arpit M. Chhabra, (unknown), Deborah Kuk, Geoffrey Y. Ku, David H. Ilson, Yelena Y. Janjigian, Abraham J. Wu, Heiko Schöder, Karyn A. Goodman	15
8	Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer 2015 ·Annals of Surgical Oncology ·Iain J. Nixon, Deborah Kuk, Volkert B. Wreesmann, Luc G.T. Morris, Frank L. Palmer, Ian Ganly, Snehal G. Patel, Bhuvanesh Singh, R. Michael Tuttle, Ashok R. Shaha, Mithat Gönen, Jatin P. Shah	80
9	Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas 2015 ·European Journal of Cancer ·Mrinal M. Gounder, (unknown), Deborah Kuk, Narasimhan P. Agaram, Maria E. Arcila, Benjamin H. Durham, Mary Louise Keohan, Mark A. Dickson, Sandra P. D’Angelo, Neerav Shukla, Craig H. Moskowitz, Ariela Noy, Robert G. Maki, Diego Adrianzen Herrera, (unknown), Anita Krishnan, (unknown), Li-Xuan Qin, William D. Tap	68
10	Computational Algorithm-Driven Evaluation of Monocytic Myeloid-Derived Suppressor Cell Frequency for Prediction of Clinical Outcomes 2014 ·Cancer Immunology Research ·Shigehisa Kitano, Michael A. Postow, Carly G.K. Ziegler, Deborah Kuk, Katherine S. Panageas, Czrina Cortez, Teresa Rasalan, Matthew Adamow, Jianda Yuan, Phillip Wong, Grégoire Altan‐Bonnet, Jedd D. Wolchok, Alexander M. Lesokhin	111
11	International Multi-institutional Management and Outcome of Melanoma Patients with Positive Sentinel Lymph Nodes in More than One Nodal Basin 2014 ·Annals of Surgical Oncology ·Laleh G. Melstrom, (unknown), Deborah Kuk, Timothy L. Frankel, Katherine S. Panageas, Lauren E. Haydu, Michael S. Sabel, John F. Thompson, Charlotte E. Ariyan, Daniel G. Coit, Mary S. Brady	13
12	Analysis of Outcomes in Extraskeletal Osteosarcoma 2014 ·Journal of Bone and Joint Surgery ·(unknown), John H. Healey, Deborah Kuk, Murray F. Brennan	45
13	Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment 2014 ·Human Pathology ·Sandra P. D’Angelo, Alexander N. Shoushtari, Narasimhan P. Agaram, Deborah Kuk, Li‐Xuan Qin, Richard D. Carvajal, Mark A. Dickson, Mrinal M. Gounder, Mary Louise Keohan, Gary K. Schwartz, William D. Tap	237
14	Prognostic Aspects of DCE-MRI in Recurrent Rectal Cancer 2013 ·European Radiology ·Marc J. Gollub, Kun Cao, David H. Gültekin, Deborah Kuk, Mithat Gönen, Michael Sohn, Lawrence H. Schwartz, Martin R. Weiser, Larissa K. Temple, Garrett M. Nash, José G. Guillem, (unknown), Julio García‐Aguilar, Karyn A. Goodman, Philip B. Paty	13
15	Bone Metastases in Castration-Resistant Prostate Cancer: Associations between Morphologic CT Patterns, Glycolytic Activity, and Androgen Receptor Expression on PET and Overall Survival 2013 ·Radiology ·Hebert Alberto Vargas, Cecilia Wassberg, Josef J. Fox, Andreas G. Wibmer, Debra A. Goldman, Deborah Kuk, Mithat Gönen, Steven M. Larson, Michael J. Morris, Howard I. Scher, Hedvig Hricak	72
16	Short-term Androgen-Deprivation Therapy Improves Prostate Cancer-Specific Mortality in Intermediate-Risk Prostate Cancer Patients Undergoing Dose-Escalated External Beam Radiation Therapy 2012 ·International Journal of Radiation OncologyBiologyPhysics ·Zachary S. Zumsteg, Daniel E. Spratt, Xin‐Hai Pei, Yoshiya Yamada, (unknown), Deborah Kuk, Zhigang Zhang, Michael J. Zeléfsky	46
17	Secondary cancers after intensity‐modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause‐specific survival outcomes according to the initial treatment intervention 2012 ·British Journal of Urology ·Michael J. Zeléfsky, Xin Pei, (unknown), Deborah Kuk, Juan Martin Magsanoc, Marisa Kollmeier, Brett Cox, Zhigang Zhang	72
18	Is Port Site Resection Necessary in the Surgical Management of Gallbladder Cancer? 2011 ·Annals of Surgical Oncology ·Ajay V. Maker, Jean M. Butte, Jacqueline Oxenberg, Deborah Kuk, Mithat Gönen, Yuman Fong, Ronald P. DeMatteo, Michael I. D’Angelica, Peter J. Allen, William R. Jarnagin	87
19	Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer 2011 ·European Radiology ·Marc J. Gollub, David H. Gültekin, Oğuz Akın, Richard Kinh Gian, James L. Fuqua, Mithat Gönen, Deborah Kuk, Martin R. Weiser, Leonard B. Saltz, Deborah Schrag, Karyn A. Goodman, Philip B. Paty, José G. Guillem, Garrett M. Nash, Larissa K. Temple, Jinru Shia, Lawrence H. Schwartz	109
20	Evaluation of serum IL-17 levels during ipilimumab therapy: Correlation with colitis. 2011 ·Journal of Clinical Oncology ·Margaret K. Callahan, Aili Yang, (unknown), Ya Xu, Sumit K. Subudhi, (unknown), (unknown), (unknown), Deborah Kuk, K. Panageas, (unknown), James P. Allison, J. D. Wolchok	102

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact